Treatment strategies in amotivated patients

Psychiatric Annals

Volumn 27, Issue 1, 1997, Pages 44-49

  Campbell III, John J ^a   Puffy, James D ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343730716     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19970101-11     Document Type: Article

References (30)

1. Marin RS. The differential diagnosis of apathy and related disorders of diminished motivation. Psychiatric Annals. 1997; 27:30-33.
2. Duffy JD. The neural substrates of motivation. Psychiatric Annals. 1997; 27:24-29.
3. Krupp B, Fogel BS. Motivational impairment in primary psychiatric and medical illness. Psychiatric Annals. 1997; 27:34-38.
4. VanKammen DP, Marder SR. Dopamine receptor antagonists. In: Kaplan HI, Saddock BJ, eds. Comprehensive Textbook of Psychiatry; Baltimore, MD: Williams & Wilkins; 1995:1987-2022.
5. Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry: a reconsideration. Arch Gen Psychiatry. 1987; 44:286-295.
6. Masand PS, Tesar GE. Use of stimulants in medically ill. Psychiatr Clin North Am. 1996; 19:515-547.
7. Lewis L, Athey GI, Eyman J, et al. Psychological treatment of adult psychiatric patients with traumatic frontal lobe injury. J Neuropsychiatry Clin Neurosci. 1992; 4:323-330.
8. Campbell JJ III, Duffy JD, Salloway SP. Treatment strategies for patients with dysexecutive syndromes. J Neuropsychiatry Clin Neurosci. 1994; 6:411-417.
9. Epstein NB, Bishop DS. Problem centered systems therapy of the family. In: Gurman A, Kniskern D, eds. Handbook of Family Therapy. New York, NY: Brunner/Mazel; 1981:444-482.
10. Marin RS, Biedrzycki RC, Firinciogullari SF. Reliability and validity of the Apathy Evaluation Scale. Paper presented at the annual meeting of the American Psychiatric Association; New York, NY; May 1990.
11. Andreasen NC. Scale for the assessment of negative symptoms (SANS). Iowa City, IA: University of Iowa; 1984.
12. Paulsen JS, Stout JC, DellaPena J, et al. Frontal behavioral syndromes in cortical and subcortical dementia. Assessment. 1996; 3:327-337.
13. Ross ED, Stewart RM. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology. 1981; 31:1435-1439.
14. Echiverri HC, Tatum WO, Merens TA, et al. Akinetic mutism: pharmacologic probe of the dopaminergic mesencephalofrontal activating system. Pediatr Neurol. 1988; 4:228-230.
15. Campagnolo DI, Katz RT. Successful treatment of akinetic mutism with a post synaptic dopamine agonist. Arch Phys Med Rehabil. 1992; 73:975.
16. Parks RW, Crockett DJ, Manji HK, et al. Assessment of bromocriptine intervention for the treatment of frontal lobe syndrome: a case study. J Neuropsychiatry Clin Neurosci. 1992; 4:109-111.
17. Catsman-Berrevoets CE, van Harskamp F. Compulsive presleep behavior and apathy due to bilateral thalamic stroke: response to bromocriptine. Neurology. 1988; 38:647-649.
18. Anderson B. Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine: case report. J Neurosurg. 1992; 76:152-155.
19. Eames P. The use of sinemet and bromocriptine. Brain Inj. 1989; 3:319-320.
20. Stewart JT, Leadon M, Gonzalez-Rothi LJ. Treatment of a case of akinetic mutism with bromocriptine. J Neuropsychiatry Clin Neurosci. 1990; 2:462-463.
21. Barrett K. Treating organic abulia with bromocriptine and lisuride: four case studies. J Neurol Neurosurg Psychiatry. 1991; 54:718-721.
22. Fleet WS, Valenstein E, Watson RT, et al. Dopamine agonist therapy for neglect in humans. Neurology. 1987; 37:1765-1770.
23. Crismon ML, Childs A, Wilcox RE, et al. The effect of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutism). Clin Neuropharmacol. 1988; 11:462-466.
24. Marin R, Fogel BF, Krupp B, et al. Apathy: a treatable disorder. J Neuropsychiatry Clin Neurosci. 1995; 7:23-30.
25. Müller U, von Cramon DY. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage. Prog NeuroPsychopharmacol Biol Psychiatry. 1994; 18:1103-1120.
26. Watanabe MD, Martin EM, DeLeon OA. Successful methylphenidate treatment of apathy after subcortical infarcts. J Neuropsychiatry Clin Neurosci. 1995; 7:502-504.
27. Dombovy ML, Wong A, Schneider W, et al. Clinical use of amantadine in brain injury rehabilitation. Arch Phys Med Rehabil. 1992; 73:975-976.
28. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc. 1975; 23:271-276.
29. Clark ANG, Mankikar GD. D-amphetamine in elderly patients refractory to rehabilitation procedures. J Am Geriatr Soc. 1979; 27:174-177.
30. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol. 1996; 9:1-6.